相关实验视频

Updated: May 9, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

在帕金森病模型中,N-乙-l-氨酸降低了ps129-synuclein,并改善了突触功能

Pingping Song¹, Rossella Franchini², Chuyu Chen³

¹Northwestern University Feinberg School of Medicine.

Research square

|April 29, 2025

概括

通过减少有毒的α-synuclein和改善神经元中的突触功能,N-乙-L-氨酸 (NALL) 在帕金森病 (PD) 中表现有前途. 这种神经保护作用在患者细胞和PD的小鼠模型中观察到.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
药理学药理学是指药理学的学科.

背景情况:

氨酸衍生物N-乙-L-氨酸 (NALL) 对像帕金森病 (PD) 这样的神经退行性疾病具有治疗潜力.
在NALL的神经保护作用的基础上的精确机制,特别是在PD中,仍然在很大程度上未被阐明.

研究的目的:

研究NALL在帕金森病中发挥保护作用的分子机制.
确定NALL对相关细胞和动物模型中的蛋白质表达,α-synuclein病理和突触功能的影响.

主要方法:

基于发现的蛋白质组学被用于分析NALL治疗的PD患者衍生的多巴胺基神经元中的蛋白质表达变化.
评估了病理性ps129-alpha-synuclein的水平和关键蛋白质如parkin的表达.
在接受NALL治疗的LRRK2突变小鼠中评估了功能性突触参数和运动学习缺陷.

主要成果:

在PD患者的多巴胺能神经元中,NALL治疗上调了溶酶体,线粒体和突触蛋白.
NALL降低了pS129-alpha-synuclein水平,这取决于HTRA1诱导,并增加了野生类型的帕金表达.
在PD的小鼠模型中,NALL治疗改善了突触功能标志物和改善了运动缺陷.

结论:

N-乙-L-氨酸通过减轻α-synuclein病理和增强突触功能来证明帕金森病的治疗潜力.
NALL的机制涉及调节与细胞平衡和神经传递有关的蛋白质表达,在脆弱的多巴胺基神经元中.

更多相关视频

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...